Epilepsy and Myasthenia Gravis: A Case Series

Overview

Journal Brain Sci

Publisher MDPI

Date 2024 Sep 28

PMID 39335366

Authors

Inigo Oyarzun

Guillermo Hernandez

Jacint Sala-Padro

Francisco Morandeira

Carlos Casasnovas

Merce Falip

Affiliations

Soon will be listed here.

Abstract

The association between epilepsy and myasthenia gravis has rarely been reported, and when it has been reported, it has only been in a small case series. The aim of the present study was to report the frequency of epilepsy and myasthenia gravis and to describe a case series of patients with myasthenia gravis and epilepsy, focusing on their clinical characteristics and searching for a possible physiopathological mechanism. A retrospective, observational, adult center study was conducted in 2022. Patients were recruited from the database of the outpatient clinic of the Myasthenia Gravis and Epilepsy Unit of the Neurology Service, Hospital Universitari de Bellvitge. Five patients were included. The frequency of epilepsy in the myasthenia gravis cohort was 5/469 (1.1%), and the frequency of myasthenia gravis in the epilepsy cohort was 5/1432 (0.35%). All patients suffered from focal epilepsy, mainly temporo-central, which was drug-resistant in 3/5 Myasthenia gravis, which was generalized and with exacerbations in 3/5. Three patients were thymectomized (anatomopathology: thymic hyperplasia). Other autoimmune diseases were found in two (40%). Epilepsy onset preceded myasthenia gravis onset in all patients. Both diseases were considered autoimmune-related in 3/5, related to genetic predisposition due to altered innate immune system in 1/5, and due to chance or to treatment in 1/5. Epilepsy and myasthenia gravis are only infrequently associated. In adult patients, epilepsy onset precedes myasthenia onset in most cases. In some cases, epilepsy has an autoimmune etiology and coexists with other autoimmune conditions.

References

Hau Man T, Shek-Kwan C, On-Kei C, Lam C . Effect of plasmapheresis on serum levels of clobazam, levetiracetam and topiramate. Epilepsy Behav Case Rep. 2017; 8:66-68. PMC: 5607118. DOI: 10.1016/j.ebcr.2017.07.002. View

Lai C, Leppik I, JENKINS D, Sood P . Epilepsy, myasthenia gravis, and effect of plasmapheresis on antiepileptic drug concentrations. Arch Neurol. 1990; 47(1):66-8. DOI: 10.1001/archneur.1990.00530010080024. View

Hehir 2nd M, Li Y . Diagnosis and Management of Myasthenia Gravis. Continuum (Minneap Minn). 2022; 28(6):1615-1642. DOI: 10.1212/CON.0000000000001161. View

Fisher R, Cross J, French J, Higurashi N, Hirsch E, Jansen F . Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58(4):522-530. DOI: 10.1111/epi.13670. View

Booker H, CHUN R, Sanguino M . Myasthenia gravis syndrome associated with trimethadione. JAMA. 1970; 212(13):2262-3. View

Sureshbabu S, Karunanidhi S, Peter S, Chindrippu S, Joseph M, Mittal G . Myasthenia gravis and insular cortex epilepsy: more than a chance association?. Acta Neurol Belg. 2021; 122(6):1619-1621. DOI: 10.1007/s13760-021-01680-8. View

Lorenzoni P, Dal-Pra Ducci R, Tensini T, Dalledone G, Suemi Kamoi Kay C, de Paola L . Treatment of epilepsy in patients with myasthenia gravis: Is really harder than it looks?. J Clin Neurosci. 2017; 44:353-356. DOI: 10.1016/j.jocn.2017.06.067. View

Scheffer I, Berkovic S, Capovilla G, Connolly M, French J, Guilhoto L . ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58(4):512-521. PMC: 5386840. DOI: 10.1111/epi.13709. View

Ong M, Kohane I, Cai T, Gorman M, Mandl K . Population-level evidence for an autoimmune etiology of epilepsy. JAMA Neurol. 2014; 71(5):569-74. PMC: 4324719. DOI: 10.1001/jamaneurol.2014.188. View

10.

Di Stefano V, Alonge P, Rini N, Militello M, Lupica A, Torrente A . Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndrome. J Neurol. 2023; 271(1):254-262. PMC: 10769952. DOI: 10.1007/s00415-023-11970-1. View

11.

Gilhus N, Tzartos S, Evoli A, Palace J, Burns T, Verschuuren J . Myasthenia gravis. Nat Rev Dis Primers. 2019; 5(1):30. DOI: 10.1038/s41572-019-0079-y. View

12.

HOEFER P, ARANOW Jr H, Rowland L . Myasthenia gravis and epilepsy. AMA Arch Neurol Psychiatry. 1958; 80(1):10-7. DOI: 10.1001/archneurpsyc.1958.02340070028002. View

13.

Troscher A, Mair K, Verdu de Juan L, Kock U, Steinmaurer A, Baier H . Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex. Brain. 2022; 146(4):1436-1452. PMC: 10115353. DOI: 10.1093/brain/awac404. View

14.

Koge J, Hayashi S, Murai H, Yokoyama J, Mizuno Y, Uehara T . Morvan's syndrome and myasthenia gravis related to familial Mediterranean fever gene mutations. J Neuroinflammation. 2016; 13(1):68. PMC: 4812638. DOI: 10.1186/s12974-016-0533-7. View

15.

Yang Y, Shen Z, Shi F, Wang F, Wen N . Efgartigimod as a novel FcRn inhibitor for autoimmune disease. Neurol Sci. 2024; 45(9):4229-4241. DOI: 10.1007/s10072-024-07460-5. View

16.

Zhu Y, Wang B, Hao Y, Zhu R . Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases. Front Immunol. 2023; 14:1223322. PMC: 10538566. DOI: 10.3389/fimmu.2023.1223322. View

17.

Kurian M, King M . Antibody positive myasthenia gravis following treatment with carbamazepine--a chance association?. Neuropediatrics. 2003; 34(5):276-7. DOI: 10.1055/s-2003-43257. View

18.

Wie Borsheim A, Engeland A, Gilhus N . Epilepsy and autoimmune diseases: Comorbidity in a national patient cohort. Seizure. 2020; 75:89-95. DOI: 10.1016/j.seizure.2019.12.015. View

19.

Schomburg L . Selenium Deficiency Due to Diet, Pregnancy, Severe Illness, or COVID-19-A Preventable Trigger for Autoimmune Disease. Int J Mol Sci. 2021; 22(16). PMC: 8395178. DOI: 10.3390/ijms22168532. View

20.

Steriade C, Britton J, Dale R, Gadoth A, Irani S, Linnoila J . Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: Conceptual definitions. Epilepsia. 2020; 61(7):1341-1351. DOI: 10.1111/epi.16571. View